Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,700 total articles
FDA approval of Optune Pax for locally advanced pancreatic cancer materially broadens NovoCure's TAM and gives the stock a near-term re-rating lever. The catalyst is clear; the trade is to buy a measured entry on the post-announcement pullback with defined stop and target.
Arhaus has pulled back to $9.13 after a bout of selling that looks more technical than structural. The business is cash-generative, lightly levered, and expanding showrooms while raising revenue guidance in recent quarters. At roughly $1.29B market cap and a P/S near 1.0, this is a buy-the-dip setup with a clear entry, stop, and target for a mid-te…
Sanofi's board removed CEO Paul Hudson effective 02/17/2026 and named Belén Garijo as incoming CEO on 04/29/2026. The stock has pulled back to $47.03 after the news but trades at a market cap of $113.95B with a P/E of 13.63 and a 3.25% dividend yield. We view the sell-off as an overreaction and recommend a mid-term long with exact entry, stop and t…
Brinker posted crisp operating progress in FY2025: same-store gains at Chili's, restaurant operating margin expansion and >$5B in revenue. Valuation is reasonable (P/E ~16, EV/EBITDA ~10) for a mid-cap casual-dining operator. This is a swing trade idea to buy strength around $162.54, target $175 and protect capital at $156 if traffic momentum stall…
Fairfax Financial (FRFHF) has enjoyed a monster rally, yet core valuation metrics - PE ~7.9 and PB ~1.42 - still argue for more upside. Market cap sits near $40.0B while the company continues to generate substantial earnings and carry a diversified insurance + investment mix. This trade proposes a long with a clear entry, stop and target and balanc…
Microsoft's share price has pulled back with software peers amid macro concern, but the company's durable cloud growth, strong free cash flow ($77.4B), and pristine balance sheet make the current levels attractive. This is a tactical upgrade to BUY with a position-sized plan and clear entry, stop, and target levels for the next 3-6 months.
Boeing has posted improving profitability metrics but still shows negative free cash flow, heavy leverage and stretched multiples. The stock is a tactical long: buy the operational momentum and service-tail gains while protecting against execution and balance-sheet shocks. Entry $239.35, stop $218.00, target $280.00 for a long-term (180 trading day…
Salesforce (CRM) has been chopped down with the rest of SaaS as AI fear and headline risk dominate tape. Fundamentals still show a durable franchise: market cap ~$174B, free cash flow near $12.9B, low net leverage, and P/E ~24. I lay out a long trade with a clear entry, stop and target for a long-term (180 trading days) rebound if the market re-rat…
AOSL is trading at bargain multiples versus sales and book value, but trailing losses and negative free cash flow mean any upside depends on margin recovery and sustained revenue. We outline a mid-term swing trade that balances upside from mean reversion and industry tailwinds against concrete downside protections.
Lululemon trades at a single-digit to mid-teens P/E with healthy cash flow and no net debt, making it historically cheap on fundamentals. Still, leadership uncertainty and continuing U.S. softness argue for a measured, position-sized long with defined stops and a multi-month horizon.
Meta has shifted from near-zero net debt to roughly $60 billion of borrowings over the last five years to fund Reality Labs and AI infrastructure. That change amplifies downside risk despite $46.1B of free cash flow and a $1.67T market cap. We lay out a mid-term short trade that exploits near-term sentiment and valuation pressure while mapping the …
Amazon has the balance sheet, customer base, and AWS scale to develop custom silicon that matters. Short-term price action and oversold technicals create a tactical long opportunity, but execution risk and capital intensity are real. This trade targets a bounce to $230 within ~45 trading days while protecting downside at $188.
Arcturus is trading like a winner despite thin cash runway, negative free cash flow, and elevated short interest. The company has a real European approval for KOSTAIVE, but the market may already be assuming rapid commercial traction and further clinical wins. This trade idea lays out a mid-term short: entry, stop, target, catalysts to watch, and t…
Neurocrine's share drop has created a tactical long opportunity. The stock is oversold after a flurry of mixed clinical updates in late 2025; fundamentals show strong cash generation, no debt, and growing revenue. Price trades at a premium but the balance sheet and franchise support a mid-term rebound. We'll outline a specific entry, stop, and targ…
Microsoft’s Azure-led migrations are a predictable, high-margin revenue stream under the headline AI investments. The stock is down from its highs, showing technical oversold signals while fundamentals - free cash flow, ROE, and low leverage - remain robust. This trade targets a mid-term bounce as recurring migration revenue re-rates the multiple.
HubSpot fell sharply amid a broad software selloff tied to AI headlines. The selloff has pushed the stock into deeply oversold territory (RSI 22.6) despite a healthy free cash flow stream ($655M) and a $11.3B market cap. This trade idea lays out an actionable buy-the-dip plan with entry, stop and target, plus catalysts and risks.
BP halted stock buybacks to prioritize debt reduction after a weak revenue print and a $3.42B loss; the shares fell but trade at a reasonable book multiple and yield ~5%. We view this as a tactical long: enter around the current level, defend with a tight stop, and target a reversion toward the $40 area over a mid-term horizon as markets re-rate fi…
GlobalFoundries (GFS) is positioned to convert recent tech deals and policy support into faster, margin-accretive growth. The stock has already re-rated, trading near its 52-week high, but several near-term catalysts and improving technicals argue for a tactical long. This trade plan targets a measured upside while protecting against execution and …
Rubrik (RBRK) is back in the 'value bin' after a sector-wide selloff pushed shares to $52.80. The company still shows strong revenue growth, positive free cash flow, and improving profitability metrics; coupled with heavy short interest and technical oversold signals, this creates a favorable mid-term trade. We initiate a long trade with clear entr…
Amazon has been hammered since earnings, sending price below key moving averages and into oversold territory. Fundamentals remain intact: AWS profitability, solid ROE, low leverage, and a $2.14T market cap. Technicals scream oversold (RSI 23.6) and short activity is elevated — conditions that favor a tactical long for mean reversion. Trade plan pro…
Opendoor (OPEN) is a speculative buy here. The stock is trading near $4.32 after a volatile run in 2025 and meaningful recent weakness. Fundamentals remain challenged — negative EPS, heavy leverage and pressure on margins — but valuation (sub-1x price-to-sales and enterprise value roughly $5.37B) and an upcoming 02/19/2026 financial open house crea…
Strategy Inc (MSTR) trades near its 52-week low despite a large range of outcomes tied to Bitcoin. The stock offers an asymmetric payoff: deep downside protection from a sub-$350B enterprise software business and outsized upside if Bitcoin regains investor confidence. This trade plan lays out an entry at $122.00, stop at $100.00, and a $220.00 targ…
Xiaomi (XIACY) is trading near the bottom of a consolidation range after aggressive profit-taking in China’s consumer and EV sectors. With a market cap of roughly $120.1B, a P/E around 19.8 and a diversified business model spanning smartphones, smart devices and internet services, the stock offers a constructive risk-reward as it digests volatility…
Klaviyo pulled back sharply to $18.50 after failing to hold $20. Management still runs a cash-generative marketing SaaS with $208.5M in free cash flow and a $5.65B market cap. With RSI near 30 and short interest modest, this dip creates a tactical entry. I prefer a mid-term swing: enter $18.55, stop $16.50, target $30.00 (about 45 trading days).
Taiwan Semiconductor (TSM) is shifting from a smartphone-driven cycle to an AI infrastructure-driven one. Recent January sales up 37% year-over-year and management guidance pointing to ~30% revenue growth make a near-term swing long attractive. This trade targets $420 with a $320 stop for a mid-term 45-trading-day holding period, balancing upside f…
